INFLAZOME LTD has a total of 221 patent applications. It increased the IP activity by 415.0%. Its first patent ever was published in 2017. It filed its patents most often in United Kingdom, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and measurement are CTXT PTY LTD, MOREPEN LAB LTD and RAZE THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 72 | |
#2 | WIPO (World Intellectual Property Organization) | 33 | |
#3 | EPO (European Patent Office) | 24 | |
#4 | United States | 17 | |
#5 | Canada | 9 | |
#6 | Australia | 8 | |
#7 | Brazil | 7 | |
#8 | Republic of Korea | 7 | |
#9 | Singapore | 7 | |
#10 | China | 6 | |
#11 | Taiwan | 6 | |
#12 | Uruguay | 6 | |
#13 | Argentina | 5 | |
#14 | Israel | 5 | |
#15 | Chile | 2 | |
#16 | Peru | 2 | |
#17 | Colombia | 1 | |
#18 | Hungary | 1 | |
#19 | Morocco | 1 | |
#20 | Montenegro | 1 | |
#21 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Measurement |
# | Name | Total Patents |
---|---|---|
#1 | Miller David | 129 |
#2 | Macleod Angus | 110 |
#3 | Shannon Jonathan | 101 |
#4 | Thom Stephen | 92 |
#5 | Cooper Matthew | 85 |
#6 | St-Gallay Stephen | 70 |
#7 | Van Wiltenburg Jimmy | 66 |
#8 | Alanine Thomas | 42 |
#9 | Strutt Ian | 39 |
#10 | Onions Stuart | 28 |
Publication | Filing date | Title |
---|---|---|
WO2021043966A1 | Nlrp3 inhibitors | |
WO2021032588A1 | Macrocyclic sulfonylamide derivatives useful as nlrp3 inhibitors | |
WO2021032591A1 | Macrocyclic sulfonylurea derivatives useful as nlrp3 inhibitors | |
GB202010792D0 | Novel compounds | |
GB202004682D0 | Novel Compounds | |
GB202004683D0 | Novel Compounds | |
GB202004681D0 | Novel Compounds | |
GB202004335D0 | Novel treatment | |
GB202003645D0 | Novel treatment | |
GB202003647D0 | Novel treatment | |
GB202002216D0 | Novel Compounds | |
GB202000810D0 | Novel treatment | |
GB202000808D0 | Novel treatment | |
GB202000805D0 | Novel treatment | |
GB202000806D0 | Novel treatment | |
GB201918076D0 | Novel compounds | |
GB201916754D0 | Novel treatment | |
GB201916236D0 | Novel treatment | |
GB201916238D0 | Novel treatment | |
GB201916237D0 | Novel treatment |